Plant-derived pyroptosis inducers as a therapeutic strategy in drug-resistant cancers

Kang Zi Khor and Adam Azlan and Nozlena Abdul Samad and Emmanuel Jairaj Moses and George George Mathew and Julia Joseph (2025) Plant-derived pyroptosis inducers as a therapeutic strategy in drug-resistant cancers. Medicinal Chemistry Research, 34. pp. 2137-2146. ISSN 1054-2523

Text FULLTEXT.pdf Restricted to Registered users only Download (576kB) | Request a copy

Abstract

Drug resistance in cancer therapy, often due to the evasion of apoptosis, highlights the need for alternative treatments. Pyroptosis is a type of inflammatory programmed cell death mediated by gasdermin proteins. It offers a promising approach as it can trigger anti-tumour immunity through cytokine release. Plant-derived compounds, rich in bioactive metabolites, can induce pyroptosis via inflammasome activation, gasdermin cleavage and reactive oxygen species (ROS) generation. Phytochemicals like curcumin, quercetin, cucurbitacin B and kaempferol selectively target cancer cells while modulating inflammation in healthy tissues. Combining these compounds with chemotherapy, immunotherapy or nanoparticle-based delivery systems enhance their therapeutic efficacy and overcome drug resistance. Despite promising preclinical findings, clinical translation remains challenging, necessitating further research to optimise safety, specificity, and delivery mechanisms. This review consolidates current knowledge on plant-derived pyroptosis inducers, highlighting their mechanisms, therapeutic potential, and future directions in combating drug-resistant cancers.

Item Type:	Article
Keyword:	Pyroptosis, Plant-derived compounds, Cancer therapy
Subjects:	Q Science > QP Physiology > QP1-(981) Physiology > QP501-801 Animal biochemistry
Department:	FACULTY > Faculty of Medicine and Health Sciences
Depositing User:	DG MASNIAH AHMAD -
Date Deposited:	13 Oct 2025 15:50
Last Modified:	13 Oct 2025 15:50
URI:	https://eprints.ums.edu.my/id/eprint/45424

Actions (login required)

View Item